Evidence map›Paper›PMID 42796280›Full record

SynthesisMedicina (Kaunas, Lithuania)2026

Factors Associated with Systemic Lupus Erythematosus-Associated Interstitial Lung Disease and Clinical Outcomes: A Systematic Review and Meta-Analysis.

Mislav Radić, Petra Šimac Prižmić, Tina Bečić, Hana Đogaš, Josipa Radić, Damir Fabijanić, Andrea Gelemanović, Dijana Perković

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mislav RadićDivision of Rheumatology, Allergology and Clinical Immunology, Department of Internal Medicine, Center of Excellence for Systemic Sclerosis in Croatia, University Hospital of Split, 21000 Split, Croatia.
Petra Šimac PrižmićDivision of Rheumatology, Allergology and Clinical Immunology, Department of Internal Medicine, Center of Excellence for Systemic Sclerosis in Croatia, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0001-8529-2345
Tina BečićCardiovascular Disease Department, University Hospital of Split, 21000 Split, Croatia.
Hana ĐogašDepartment of Neurology, University Hospital of Split, 21000 Split, Croatia.
Josipa RadićSchool of Medicine, University of Split, 21000 Split, Croatia.
Damir FabijanićSchool of Medicine, University of Split, 21000 Split, Croatia.
Andrea GelemanovićMediterranean Institute for Life Sciences, University of Split, 21000 Split, Croatia.ORCID 0000-0001-9195-646X
Dijana PerkovićDivision of Rheumatology, Allergology and Clinical Immunology, Department of Internal Medicine, Center of Excellence for Systemic Sclerosis in Croatia, University Hospital of Split, 21000 Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung Diseases, InterstitialLupus Erythematosus, SystemicHumansObservational Studies as TopicRaynaud DiseaseRisk Factorsassociated factorsinterstitial lung diseaseprognosispulmonary fibrosisRaynaud phenomenonsystemic lupus erythematosus

Identifiers

PMID42796280
PMCPMC13609442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.